Inquiring Into Benefits of Independent Activation of Nonclassical Renin-angiotensin System in the Clinical Prognosis and Reduction of COVID-19 Mortality.
作者信息
Álvarez-Aragón Luis Miguel, Cuesta-Muñoz Antonio Luis, Álvarez-López Inmaculada
机构信息
Internal Medicine Department, Diabetes and Vascular Risk Unit, Hospital Comarcal de la Merced, Osuna, Seville, Spain.
International Institute of Genetics of Diabetes and International Medical Academy, Santa Elena Hospital, Torremolinos, Málaga, Spain.
出版信息
Clin Infect Dis. 2020 Jul 28;71(15):894-895. doi: 10.1093/cid/ciaa402.
Abstract
摘要
相似文献
1
Inquiring Into Benefits of Independent Activation of Nonclassical Renin-angiotensin System in the Clinical Prognosis and Reduction of COVID-19 Mortality.探究非经典肾素-血管紧张素系统的独立激活在COVID-19临床预后及降低死亡率方面的益处。
Clin Infect Dis. 2020 Jul 28;71(15):894-895. doi: 10.1093/cid/ciaa402.
2
Renin-Angiotensin-Aldosterone System Inhibitors Impact on COVID-19 Mortality: What's Next for ACE2?肾素-血管紧张素-醛固酮系统抑制剂对2019冠状病毒病死亡率的影响：血管紧张素转换酶2的下一步是什么？
Clin Infect Dis. 2020 Nov 19;71(16):2129-2131. doi: 10.1093/cid/ciaa627.
3
RAAS Inhibitors and Risk of Covid-19.肾素-血管紧张素-醛固酮系统抑制剂与新型冠状病毒肺炎风险
N Engl J Med. 2020 Nov 12;383(20):1991-1992. doi: 10.1056/NEJMc2030446. Epub 2020 Oct 27.
4
RAAS Inhibitors and Risk of Covid-19.肾素-血管紧张素-醛固酮系统抑制剂与2019冠状病毒病风险
N Engl J Med. 2020 Nov 12;383(20):1990-1991. doi: 10.1056/NEJMc2030446. Epub 2020 Oct 27.
5
Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With SARS-CoV-2 Pneumonia: A Case Series Study.肾素-血管紧张素-醛固酮系统抑制剂与新型冠状病毒肺炎患者的预后：一项病例系列研究。
Hypertension. 2020 Aug;76(2):e10-e12. doi: 10.1161/HYPERTENSIONAHA.120.15312. Epub 2020 May 8.
6
Clinical Impact of Renin-angiotensin System Inhibitors on In-hospital Mortality of Patients With Hypertension Hospitalized for Coronavirus Disease 2019.肾素-血管紧张素系统抑制剂对因2019冠状病毒病住院的高血压患者院内死亡率的临床影响
Clin Infect Dis. 2020 Jul 28;71(15):899-901. doi: 10.1093/cid/ciaa492.
7
Obesity and COVID-19.肥胖与2019冠状病毒病
Front Endocrinol (Lausanne). 2020 Sep 30;11:581356. doi: 10.3389/fendo.2020.581356. eCollection 2020.
8
COVID-19: The heart of the issue.新冠病毒：问题的核心。
J Card Surg. 2020 Aug;35(8):2112. doi: 10.1111/jocs.14684. Epub 2020 Jun 16.
9
Cardiovascular disease and the impact of COVID-19.心血管疾病与2019冠状病毒病的影响
J Card Surg. 2020 Aug;35(8):2113. doi: 10.1111/jocs.14682. Epub 2020 Jun 16.
10
COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure.心力衰竭背景下COVID-19对肾素-血管紧张素系统的干扰
mBio. 2020 May 22;11(3):e00946-20. doi: 10.1128/mBio.00946-20.
引用本文的文献
1
[Solving one of the pieces of the puzzle: COVID-19 and type 2 diabetes].[解决谜题的其中一块：2019冠状病毒病与2型糖尿病]
Rev Clin Esp. 2020 Nov;220(8):507-510. doi: 10.1016/j.rce.2020.05.003. Epub 2020 May 18.
2
Narrative review on clinical considerations for patients with diabetes and COVID-19: More questions than answers.关于糖尿病和 COVID-19 患者临床注意事项的叙述性综述：问题多于答案。
Int J Clin Pract. 2021 Nov;75(11):e14833. doi: 10.1111/ijcp.14833. Epub 2021 Sep 21.
3
[Solving one of the pieces of the puzzle: COVID-19 and type 2 diabetes].[解开谜题的一部分：2019冠状病毒病与2型糖尿病]
Rev Clin Esp (Barc). 2020 Nov;220(8):507-510. doi: 10.1016/j.rce.2020.05.003. Epub 2020 May 18.
Zotero 插件